| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Matthew Stanton last filed a Form 4 in October 2024, as Chief Scientific Officer at GBIO. From December 2020 to October 2024, the filings on record show 0 open-market purchases and 17 sales. Matthew Stanton's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Matthew Stanton a strong insider score of 91/100, based on 15 past trades. Over a 12-month horizon, all 15 of those trades were profitable, with an average 12-month return of +77.2%.
At the last filing, the largest reported position was 247,319 shares of GBIO. The GBIO filings lean toward selling, a net 93,890 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 1,500 | $28.03 | $42,045.00 | -0.8% | -29.3% | -72.1% | |
| Apr 12, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 6,000 | $26.24 | $157,446.00 | -2.9% | -8.4% | -66.0% | |
| Mar 10, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 10,500 | $34.97 | $367,209.50 | -5.0% | -21.2% | -86.4% | |
| Feb 10, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 10,400 | $34.60 | $359,855.69 | -5.0% | - | - | |
| Jan 14, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 5,630 | $32.54 | $183,212.40 | -2.8% | - | - | |
| Jan 11, 2021 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 14,820 | $27.69 | $410,372.19 | -7.0% | - | - | |
| Dec 10, 2020 | GBIO Generation Bio Co. | Chief Scientific Officer | Sale+OE | 10,540 | $37.62 | $396,498.94 | -5.1% | - | - |